Sorrento Therapeutics, Inc. (SRNE)
USD 0.0
(42.86%)
USD 0.0
(42.86%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | 29.38 Million USD | -26.3% |
| 2021 | 39.87 Million USD | 32.71% |
| 2020 | 30.04 Million USD | 56.53% |
| 2019 | 19.19 Million USD | 72.55% |
| 2018 | 11.12 Million USD | -92.1% |
| 2017 | 140.83 Million USD | 3060.48% |
| 2016 | 4.45 Million USD | 68.79% |
| 2015 | 2.64 Million USD | 48.15% |
| 2014 | 1.78 Million USD | 291.04% |
| 2013 | 455.7 Thousand USD | -21.94% |
| 2012 | 583.77 Thousand USD | 10.32% |
| 2011 | 529.18 Thousand USD | -22.47% |
| 2010 | 682.56 Thousand USD | 12509.79% |
| 2009 | 5413.00 USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q1 | 11.06 Million USD | 491.08% |
| 2023 Q2 | 6.57 Million USD | -40.61% |
| 2022 Q4 | 1.87 Million USD | -79.5% |
| 2022 Q3 | 9.13 Million USD | 58.62% |
| 2022 FY | 29.38 Million USD | -26.3% |
| 2022 Q2 | 5.75 Million USD | -54.41% |
| 2022 Q1 | 12.62 Million USD | 41.81% |
| 2021 Q1 | 10.86 Million USD | 21.8% |
| 2021 Q2 | 10.39 Million USD | -4.41% |
| 2021 Q3 | 5.61 Million USD | -45.92% |
| 2021 Q4 | 8.9 Million USD | 58.46% |
| 2021 FY | 39.87 Million USD | 32.71% |
| 2020 Q3 | 9.08 Million USD | 34.39% |
| 2020 FY | 30.04 Million USD | 56.53% |
| 2020 Q2 | 6.75 Million USD | 27.94% |
| 2020 Q1 | 5.28 Million USD | -54.51% |
| 2020 Q4 | 8.92 Million USD | -1.74% |
| 2019 Q2 | 3.19 Million USD | -16.66% |
| 2019 Q4 | 11.61 Million USD | 2003.62% |
| 2019 FY | 19.19 Million USD | 72.55% |
| 2019 Q1 | 3.83 Million USD | -16.34% |
| 2019 Q3 | 552 Thousand USD | -82.73% |
| 2018 Q2 | 2.68 Million USD | -45.55% |
| 2018 Q4 | 4.58 Million USD | 137.76% |
| 2018 FY | 11.12 Million USD | -92.1% |
| 2018 Q1 | 4.93 Million USD | -74.6% |
| 2018 Q3 | 1.92 Million USD | -28.25% |
| 2017 Q3 | 120.82 Million USD | 3039.13% |
| 2017 Q1 | 3.81 Million USD | 29.28% |
| 2017 FY | 140.83 Million USD | 3060.48% |
| 2017 Q4 | 19.42 Million USD | -83.92% |
| 2017 Q2 | 3.84 Million USD | 1.02% |
| 2016 FY | 4.45 Million USD | 68.79% |
| 2016 Q2 | 607 Thousand USD | -3.5% |
| 2016 Q1 | 629 Thousand USD | -22.73% |
| 2016 Q3 | 1.82 Million USD | 200.66% |
| 2016 Q4 | 2.94 Million USD | 61.48% |
| 2015 Q2 | 859 Thousand USD | 83.55% |
| 2015 FY | 2.64 Million USD | 48.15% |
| 2015 Q3 | 499 Thousand USD | -41.91% |
| 2015 Q4 | 814 Thousand USD | 63.13% |
| 2015 Q1 | 468 Thousand USD | 31.83% |
| 2014 Q1 | 413 Thousand USD | 329.06% |
| 2014 FY | 1.78 Million USD | 291.04% |
| 2014 Q3 | 749 Thousand USD | 182.64% |
| 2014 Q2 | 265 Thousand USD | -35.84% |
| 2014 Q4 | 355 Thousand USD | -52.6% |
| 2013 Q3 | 83.79 Thousand USD | -40.82% |
| 2013 FY | 455.7 Thousand USD | -21.94% |
| 2013 Q1 | 134.06 Thousand USD | 9.9% |
| 2013 Q4 | 96.25 Thousand USD | 14.88% |
| 2013 Q2 | 141.59 Thousand USD | 5.62% |
| 2012 Q3 | 134.5 Thousand USD | -38.05% |
| 2012 FY | 583.77 Thousand USD | 10.32% |
| 2012 Q2 | 217.13 Thousand USD | 97.13% |
| 2012 Q1 | 110.14 Thousand USD | -13.88% |
| 2012 Q4 | 121.98 Thousand USD | -9.31% |
| 2011 Q1 | 235.36 Thousand USD | -54.01% |
| 2011 Q3 | 91.75 Thousand USD | 23.73% |
| 2011 FY | 529.18 Thousand USD | -22.47% |
| 2011 Q2 | 74.15 Thousand USD | -68.49% |
| 2011 Q4 | 127.9 Thousand USD | 39.4% |
| 2010 Q4 | 511.77 Thousand USD | 347.62% |
| 2010 Q1 | - USD | -100.0% |
| 2010 Q2 | 56.46 Thousand USD | 0.0% |
| 2010 Q3 | 114.33 Thousand USD | 102.48% |
| 2010 FY | 682.56 Thousand USD | 12509.79% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | 5413.00 USD | 0.0% |
| 2009 Q4 | 5413.00 USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | 75.607% |
| Jaguar Health, Inc. | 7.72 Million USD | -280.463% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 4525.753% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 587840.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 98.064% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 75.46% |
| ContextLogic Inc. | 59 Million USD | 50.192% |
| MiMedx Group, Inc. | 266.84 Million USD | 88.987% |
| MEI Pharma, Inc. | 49.32 Million USD | 40.424% |
| AlloVir, Inc. | -398 Thousand USD | 7483.668% |
| Novavax, Inc. | 639.93 Million USD | 95.408% |
| Aptorum Group Limited | -1.11 Million USD | 2736.343% |
| Ardelyx, Inc. | 106.66 Million USD | 72.448% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 87.793% |
| Psyence Biomedical Ltd. | -240.00 USD | 12244683.333% |
| Vaxcyte, Inc. | -75 Million USD | 139.183% |
| Precigen, Inc. | 106 Thousand USD | -27623.585% |
| Pharming Group N.V. | 220.1 Million USD | 86.649% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -5606.214% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -2812.488% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 73.229% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 116.199% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 5786.933% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 122.689% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 164.836% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 233.656% |
| Acelyrin, Inc. | -115 Thousand USD | 25653.913% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 5246.585% |
| Senti Biosciences, Inc. | -2.68 Million USD | 1195.304% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -625.426% |
| AbCellera Biologics Inc. | 38.02 Million USD | 22.717% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 712.484% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -24389.167% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -0.886% |
| Chimerix, Inc. | 324 Thousand USD | -8970.062% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -5824.798% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 35937.805% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 194.287% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 6072.967% |
| Elevation Oncology, Inc. | -39 Thousand USD | 75451.282% |
| Alkermes plc | 1.37 Billion USD | 97.862% |
| Fortress Biotech, Inc. | 57.85 Million USD | 49.204% |
| Fortress Biotech, Inc. | 57.85 Million USD | 49.204% |
| Agenus Inc. | 139.61 Million USD | 78.951% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -77.276% |
| Dyadic International, Inc. | 922.95 Thousand USD | -3084.005% |
| ImmuCell Corporation | 4.39 Million USD | -568.451% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -39.533% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 127.691% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 16907.65% |
| Immix Biopharma, Inc. | -5468.00 USD | 537535.991% |
| Incyte Corporation | 3.44 Billion USD | 99.146% |
| IO Biotech, Inc. | -756 Thousand USD | 3987.169% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 162.74% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 319.998% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 66604.481% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 129.92% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 53530.909% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -3564.214% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 5676.281% |
| NextCure, Inc. | -3.68 Million USD | 897.693% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -54.319% |
| Onconetix, Inc. | -1.12 Million USD | 2707.16% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 201.446% |
| Opthea Limited | 21.72 Thousand USD | -135199.263% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 51362.952% |
| PureTech Health plc | -1.6 Million USD | 1933.25% |
| Pyxis Oncology, Inc. | -2 Million USD | 1569.35% |
| Seer, Inc. | 7.02 Million USD | -318.201% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 292478.868% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -273.358% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 845.475% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -6830.896% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 71.77% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 78.275% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 130.312% |
| ChromaDex Corporation | 50.78 Million USD | 42.129% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 12766.81% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 137.871% |
| CRISPR Therapeutics AG | 240.95 Million USD | 87.804% |
| Precision BioSciences, Inc. | 40.47 Million USD | 27.389% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 129.937% |
| Innoviva, Inc. | 261.06 Million USD | 88.743% |
| Summit Therapeutics Inc. | -2.05 Million USD | 1533.512% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -571.243% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -36.398% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 24901.04% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 20607.184% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -4725.452% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 90.631% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -1041.686% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 58016.831% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 514.018% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 6292.669% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 282667.308% |
| Soligenix, Inc. | 97.31 Thousand USD | -30099.053% |
| Century Therapeutics, Inc. | -10.8 Million USD | 371.875% |
| Kura Oncology, Inc. | -849 Thousand USD | 3561.366% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 143.793% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 20091.156% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 70.328% |
| Autolus Therapeutics plc | -4.86 Million USD | 703.801% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 28.993% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 17592.262% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 68.976% |
| GRI Bio, Inc. | 10.84 Million USD | -171.073% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -1056.975% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 438.287% |
| IGM Biosciences, Inc. | -211.66 Million USD | 113.884% |
| INmune Bio, Inc. | 155 Thousand USD | -18859.355% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 52.555% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 2050.951% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 4631.856% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 100486.008% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -7210.199% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 1572.295% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 9488.818% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 68.89% |
| Verastem, Inc. | -62 Thousand USD | 47498.387% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -1106.858% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 11359.387% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -870.829% |
| Histogen Inc. | 3.76 Million USD | -679.703% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -5000.325% |
| Surrozen, Inc. | -27.23 Million USD | 207.921% |
| Organovo Holdings, Inc. | -5.38 Million USD | 645.315% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 2538.998% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 214.583% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -46.554% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 1484291.919% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -384.421% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 43875.603% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 81.015% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -20055.693% |
| Apollomics, Inc. | 127 Thousand USD | -23039.37% |
| Amarin Corporation plc | 165.54 Million USD | 82.248% |
| Mesoblast Limited | -9.81 Million USD | 399.409% |
| Turnstone Biologics Corp. | 16.5 Million USD | -78.038% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 126.597% |
| Synaptogenix, Inc. | -6347.00 USD | 463106.145% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 57721.569% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 81.788% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 98.328% |
| Better Therapeutics, Inc. | -2.72 Million USD | 1176.841% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 126.201% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 91.308% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 257699.93% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 569.441% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 2752.256% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -301.571% |
| Insmed Incorporated | 239.63 Million USD | 87.737% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -721.325% |
| OmniAb, Inc. | 14.66 Million USD | -100.361% |
| Alector, Inc. | -95.05 Million USD | 130.916% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 76.607% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 167.614% |
| Zai Lab Limited | 170.9 Million USD | 82.805% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 64.108% |
| Aura Biosciences, Inc. | -1.29 Million USD | 2369.266% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -22505.385% |
| Immunic, Inc. | -111 Thousand USD | 26574.775% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -85.36% |
| Veracyte, Inc. | 248.14 Million USD | 88.157% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 100.42% |
| FibroGen, Inc. | 128.9 Million USD | 77.202% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 5210560.993% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 351.884% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 99.135% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -7454.499% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 91.73% |
| TG Therapeutics, Inc. | 219.1 Million USD | 86.588% |
| Galecto, Inc. | -830 Thousand USD | 3640.602% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 2221.805% |
| Fortrea Holdings Inc. | 424 Million USD | 93.069% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 134.105% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 5282.892% |
| XBiotech Inc. | -1.74 Million USD | 1785.034% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 2752.256% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 163.237% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 138.906% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 59.965% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -74.891% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 92.446% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 159.192% |
| Vaxxinity, Inc. | -2.23 Million USD | 1415.443% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 91.006% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 359.514% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -20.187% |
| NexImmune, Inc. | -1.02 Million USD | 2967.103% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -544103.704% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 513.572% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.74% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 44074.741% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 927.57% |
| Ainos, Inc. | -253.73 Thousand USD | 11681.86% |
| Pluri Inc. | 322 Thousand USD | -9026.398% |
| Prothena Corporation plc | -129.2 Million USD | 122.745% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 41.72% |
| Celularity Inc. | 6.75 Million USD | -335.041% |
| Rallybio Corporation | -150 Thousand USD | 19691.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 190.125% |
| MeiraGTx Holdings plc | 287 Thousand USD | -10139.373% |
| Omeros Corporation | -69.77 Million USD | 142.114% |
| Humacyte, Inc. | -76.55 Million USD | 138.389% |
| Immunocore Holdings plc | 248.39 Million USD | 88.169% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 293.731% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 52.892% |
| Blueprint Medicines Corporation | 236.58 Million USD | 87.579% |
| CalciMedica, Inc. | -58 Thousand USD | 50767.241% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 2160.799% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -1.143% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 1133.298% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 195.211% |
| Pulmatrix, Inc. | -8.22 Million USD | 457.506% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 2611.709% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 7465.163% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 107.369% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -958.768% |
| Cytokinetics, Incorporated | -322.59 Million USD | 109.11% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -3308.75% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 8717.889% |
| Vor Biopharma Inc. | -3.49 Million USD | 941.552% |
| Roivant Sciences Ltd. | 109.23 Million USD | 73.097% |
| Evogene Ltd. | 1.39 Million USD | -2000.572% |
| ProKidney Corp. | -3.16 Million USD | 1027.327% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 166.922% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -328.569% |
| CorMedix Inc. | -205.56 Thousand USD | 14395.93% |
| BioLineRx Ltd. | 1.1 Million USD | -2552.256% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 137.354% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 89151.515% |
| Atai Life Sciences N.V. | -5000.00 USD | 587840.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 24215.576% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 30711.458% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 2215.695% |
| Sagimet Biosciences Inc. | 2 Million USD | -1369.35% |
| MediciNova, Inc. | 979.7 Thousand USD | -2899.576% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 134.852% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 31179.266% |
| GeoVax Labs, Inc. | -20.72 Million USD | 241.824% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 87.982% |
| Biomea Fusion, Inc. | -4.2 Million USD | 799.524% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 96.631% |
| Mereo BioPharma Group plc | 7.42 Million USD | -295.731% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 9579.677% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 244991.667% |
| Absci Corporation | -41.84 Million USD | 170.222% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 587840.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 138.478% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 1294.108% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 86.251% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 3222.954% |
| Allakos Inc. | -6.14 Million USD | 578.538% |
| Imunon, Inc. | -720 Thousand USD | 4181.499% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 142.592% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 93.825% |
| BioAtla, Inc. | -103.73 Million USD | 128.33% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 257699.93% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 16609.551% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 112.102% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 9549.196% |
| XOMA Corporation | 3.86 Million USD | -661.124% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 141.931% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -98.641% |
| aTyr Pharma, Inc. | -2.38 Million USD | 1330.611% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -135.851% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 101434.483% |
| Viridian Therapeutics, Inc. | -1 Million USD | 3015.377% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -226053746.154% |
| Akari Therapeutics, Plc | -4000.00 USD | 734775.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 95.386% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -14992.857% |
| UroGen Pharma Ltd. | 73.35 Million USD | 59.937% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 210.088% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -253018.002% |
| Orgenesis Inc. | -5.72 Million USD | 613.31% |
| Entera Bio Ltd. | -56 Thousand USD | 52576.786% |
| GH Research PLC | -315 Thousand USD | 9429.206% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 15648.677% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 5697.524% |
| Xencor, Inc. | -85.26 Million USD | 134.468% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 13398.669% |
| Replimune Group, Inc. | -2.65 Million USD | 1206.855% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 3035.072% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 83.476% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -14992.857% |
| Portage Biotech Inc. | -54 Thousand USD | 54520.37% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 31179.266% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 7894.96% |
| OncoCyte Corporation | 413 Thousand USD | -7015.496% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 653870.857% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 13237487.387% |
| Purple Biotech Ltd. | -196 Thousand USD | 15093.367% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -227.687% |
| scPharmaceuticals Inc. | 9.78 Million USD | -200.419% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 381.351% |
| HilleVax, Inc. | -2.15 Million USD | 1463.033% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 30395.876% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 195961.104% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 4499.251% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 127869.565% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 391605.11% |
| Savara Inc. | -44.26 Million USD | 166.393% |
| Curis, Inc. | 9.81 Million USD | -199.531% |
| Daré Bioscience, Inc. | 2.76 Million USD | -961.086% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 23649.54% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 1799.653% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 12989.035% |
| BeiGene, Ltd. | 2.07 Billion USD | 98.586% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 1151.075% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 107.353% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 48.16% |
| Erasca, Inc. | -3.73 Million USD | 887.433% |
| bluebird bio, Inc. | -4.03 Million USD | 829.206% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 104242.746% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 98.457% |
| DBV Technologies S.A. | 15.72 Million USD | -86.845% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 104242.746% |
| Moderna, Inc. | 2.15 Billion USD | 98.636% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 3311.694% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -267.062% |
| Molecular Templates, Inc. | 50.39 Million USD | 41.687% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 5582.649% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 78.035% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 572.308% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 174.694% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 126.444% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 919.036% |
| MacroGenics, Inc. | 50.52 Million USD | 41.839% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 581.912% |
| Prime Medicine, Inc. | -147.9 Million USD | 119.869% |
| Aditxt, Inc. | -111.66 Thousand USD | 26418.288% |
| Adagene Inc. | 18.11 Million USD | -62.256% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -5921.926% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 79.04% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 81.381% |
| SciSparc Ltd. | 2.19 Million USD | -1238.206% |
| Vericel Corporation | 135.57 Million USD | 78.324% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 117418.057% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 94951.849% |
| Generation Bio Co. | -73.91 Million USD | 139.76% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 6824.714% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 46.196% |
| Invivyd, Inc. | -2.02 Million USD | 1549.063% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 109.768% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 28510.255% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 69.505% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 70.101% |
| ADMA Biologics, Inc. | 88.21 Million USD | 66.688% |
| Clene Inc. | 533 Thousand USD | -5413.508% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -21.891% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 3170.742% |
| GeoVax Labs, Inc. | -20.72 Million USD | 241.824% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -1378.219% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 15223.304% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 40.996% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 514.368% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 3615.191% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 64.77% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -40094.496% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 44.722% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 116.968% |
| Trevena, Inc. | 1.45 Million USD | -1919.725% |
| Surrozen, Inc. | -27.23 Million USD | 207.921% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 8424.929% |
| Cingulate Inc. | -582.91 Thousand USD | 5141.361% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 94896.774% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 249.18% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 388303.435% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 3435.641% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 95.683% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 3074.393% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 52258.248% |
| Kronos Bio, Inc. | 1.37 Million USD | -2041.91% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 154.759% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 10164.041% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 6118.054% |
| ImmunityBio, Inc. | -17.89 Million USD | 264.265% |
| Korro Bio, Inc. | -3.63 Million USD | 909.559% |
| Kineta, Inc. | 5.43 Million USD | -440.898% |
| BioVie Inc. | -229.37 Thousand USD | 12911.659% |
| Codexis, Inc. | 57.33 Million USD | 48.744% |
| Celularity Inc. | 6.75 Million USD | -335.041% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -632.295% |
| Celcuity Inc. | -142.77 Thousand USD | 20683.168% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -57988.555% |
| Cibus, Inc. | 1.42 Million USD | -1966.596% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 7957.487% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 228.221% |
| IN8bio, Inc. | -2.5 Million USD | 1275.01% |
| Kodiak Sciences Inc. | -25.94 Million USD | 213.258% |
| Annexon, Inc. | -3.26 Million USD | 999.51% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 1537.72% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 170.41% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -4491.719% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 96.225% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 83.009% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 1646.684% |
| Arcellx, Inc. | 108.27 Million USD | 72.86% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 190.787% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 62.897% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 238.932% |
| Moolec Science SA | -143.3 Thousand USD | 20606.612% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 169.443% |
| Geron Corporation | -123.5 Million USD | 123.795% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -794.037% |
| Royalty Pharma plc | 1.79 Billion USD | 98.362% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 141.928% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 813693.577% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -12600.148% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 126.376% |
| Humacyte, Inc. | -76.55 Million USD | 138.389% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 3196.06% |
| 89bio, Inc. | -273 Thousand USD | 10864.469% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 2437.868% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 3565.448% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 23991.87% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -2526.184% |
| Notable Labs, Ltd. | 113 Thousand USD | -25906.195% |
| Liquidia Corporation | 14.6 Million USD | -101.281% |
| Mustang Bio, Inc. | -2.22 Million USD | 1420.764% |
| Immunovant, Inc. | -231 Thousand USD | 12821.645% |
| Quantum-Si incorporated | 488 Thousand USD | -5921.926% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 152.893% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 98056.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -1478.249% |
| Acasti Pharma Inc. | -11 Thousand USD | 267254.545% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 14461.954% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 4631.856% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 117.543% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -2490.121% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 7813.123% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 1600.868% |
| PepGen Inc. | -1.18 Million USD | 2582.01% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 23239.37% |
| United Therapeutics Corporation | 2.07 Billion USD | 98.58% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 228.344% |
| Solid Biosciences Inc. | -76.56 Million USD | 138.383% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 35684.806% |
| Immuneering Corporation | -764.13 Thousand USD | 3945.771% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -44248.364% |
| Belite Bio, Inc | -399 Thousand USD | 7465.163% |
| XOMA Corporation | 3.86 Million USD | -661.124% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 246.671% |
| Bionomics Limited | -434.44 Thousand USD | 6864.2% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 2836.22% |
| uniQure N.V. | 2.21 Million USD | -1226.727% |
| Cassava Sciences, Inc. | -89.42 Million USD | 132.863% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 131.918% |
| Forte Biosciences, Inc. | -9000.00 USD | 326622.222% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 3619.401% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 6824.714% |
| Altimmune, Inc. | -65.37 Million USD | 144.953% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 91.883% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 2836.22% |
| Compugen Ltd. | 31.45 Million USD | 6.574% |
| Peak Bio, Inc. | 367.76 Thousand USD | -7890.614% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -19.869% |
| Benitec Biopharma Inc. | 108 Thousand USD | -27110.185% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 37775.641% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 2542.81% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 1712.898% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 24794.958% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 2542.81% |
| Instil Bio, Inc. | -4.75 Million USD | 717.893% |
| argenx SE | 1.1 Billion USD | 97.349% |
| Immunome, Inc. | -8.9 Million USD | 429.932% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 1654.868% |
| Verona Pharma plc | -679.62 Thousand USD | 4424.009% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 16892.571% |
| Shattuck Labs, Inc. | -2.38 Million USD | 1332.159% |
| CervoMed Inc. | -1.29 Million USD | 2371.675% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 1320.897% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 715.177% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -1089.276% |
| Moolec Science SA | -143.3 Thousand USD | 20606.612% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 7302.167% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 1200.007% |
| AnaptysBio, Inc. | 14.78 Million USD | -98.816% |
| Design Therapeutics, Inc. | -537 Thousand USD | 5572.439% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 6982.201% |
| NeurAxis, Inc. | 2.15 Million USD | -1262.588% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -1269.385% |
| Lumos Pharma, Inc. | 2 Million USD | -1364.225% |
| Achilles Therapeutics plc | -4.73 Million USD | 721.123% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 16892.571% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 27908.848% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 7.176% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -3308.75% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 2947.578% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 164.519% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -68241.86% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 3675.061% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 223439.413% |
| Palisade Bio, Inc. | 246 Thousand USD | -11845.935% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 89151.515% |
| Beam Therapeutics Inc. | -59.67 Million USD | 149.248% |
| Neurogene Inc. | -3.26 Million USD | 1000.889% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 78.909% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 895.964% |
| Sesen Bio, Inc. | 40 Million USD | 26.533% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 9994.613% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 829.742% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 407.203% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -108.714% |
| Athira Pharma, Inc. | -969 Thousand USD | 3132.714% |
| Vaccinex, Inc. | -16 Million USD | 283.623% |
| HCW Biologics Inc. | -574.82 Thousand USD | 5212.347% |
| XOMA Corporation | 3.86 Million USD | -661.124% |
| Nektar Therapeutics | 53.47 Million USD | 45.048% |
| Arvinas, Inc. | 71.8 Million USD | 59.071% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 135.21% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 146.813% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 9226.398% |
| Rezolute, Inc. | -36 Thousand USD | 81730.556% |
| Clene Inc. | 533 Thousand USD | -5413.508% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 2288807.165% |
| BeyondSpring Inc. | 1.75 Million USD | -1578.298% |
| Synlogic, Inc. | -1.92 Million USD | 1627.391% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 79524.324% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 564.103% |
| Peak Bio, Inc. | 367.76 Thousand USD | -7890.614% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 254.97% |
| Krystal Biotech, Inc. | 47.6 Million USD | 38.269% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 79.172% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -484.816% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 1234.975% |
| MannKind Corporation | 136.19 Million USD | 78.422% |
| Ikena Oncology, Inc. | -50.49 Million USD | 158.201% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 72.993% |
| Gossamer Bio, Inc. | -4.38 Million USD | 770.171% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 11761.508% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 587840.0% |
| Legend Biotech Corporation | 140.92 Million USD | 79.148% |
| Mural Oncology plc | -2.56 Million USD | 1244.799% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 5433.394% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 29487.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -41.597% |
| REGENXBIO Inc. | 53.02 Million USD | 44.583% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 648.577% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 15375.893% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 1796.709% |
| Vaxart, Inc. | -60.76 Million USD | 148.363% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 11283.119% |
| Cellectis S.A. | 18 Thousand USD | -163161.111% |
| Longeveron Inc. | 221 Thousand USD | -13197.285% |
| Repare Therapeutics Inc. | -80.07 Million USD | 136.702% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 97.311% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 2371.02% |
| Revolution Medicines, Inc. | -399.66 Million USD | 107.353% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 84062.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -59873.469% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.659% |
| Denali Therapeutics Inc. | -93.34 Million USD | 131.482% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 117418.057% |
| Veru Inc. | 7.56 Million USD | -288.412% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 19561.589% |
| Cingulate Inc. | -582.91 Thousand USD | 5141.361% |
| Passage Bio, Inc. | -3.72 Million USD | 889.761% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 244097.011% |
| Exicure, Inc. | -1.42 Million USD | 2165.144% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 7772.846% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -987.199% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 5832.091% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 56.864% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 19742.797% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 149.635% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -7415.857% |
| OmniAb, Inc. | 14.66 Million USD | -100.361% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -46.986% |
| Lipocine Inc. | -2.85 Million USD | 1130.827% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 1694.52% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 615.11% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 2050.951% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 60.982% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 45310.769% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 65.138% |
| Ocugen, Inc. | -33.53 Million USD | 187.626% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 1029.38% |
| Q32 Bio Inc. | 578 Thousand USD | -4984.256% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 11189.434% |
| Alumis Inc. Common Stock | -1.28 Million USD | 2388.707% |
| Equillium, Inc. | 35.95 Million USD | 18.274% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 1821.558% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -5769.429% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 710961.151% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 11446.332% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -6852.015% |
| Dominari Holdings Inc. | 2.03 Million USD | -1341.246% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 16117.245% |
| vTv Therapeutics Inc. | -13.59 Million USD | 316.16% |
| Bio-Techne Corporation | 773.07 Million USD | 96.199% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -69.681% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 93.622% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 2613.858% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 222.548% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -151.235% |
| Nkarta, Inc. | -5.86 Million USD | 600.716% |
| BioCardia, Inc. | -7.24 Million USD | 505.394% |
| Iterum Therapeutics plc | -1.75 Million USD | 1779.257% |